117 related articles for article (PubMed ID: 5131860)
1. Enhanced glucose oxidation by leukocytes incubated with sera from patients with rheumatoid arthritis and systemic lupus erythematosus (SLE).
Skosey JL; Sorensen LB
J Lab Clin Med; 1971 Dec; 78(6):977. PubMed ID: 5131860
[No Abstract] [Full Text] [Related]
2. Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method.
Wenger ME; Bole GG
J Lab Clin Med; 1973 Sep; 82(3):513-21. PubMed ID: 4728296
[No Abstract] [Full Text] [Related]
3. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
[TBL] [Abstract][Full Text] [Related]
4. [Interferon reaction of leukocytes in diffuse connective tissue diseases].
Pitenov VA; Etkind GV; Bektemirov TA; Alekberova ZS; Barinskiĭ IF
Sov Med; 1976 Dec; (12):21-6. PubMed ID: 1013787
[No Abstract] [Full Text] [Related]
5. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
6. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis.
Gabay C; Roux-Lombard P; de Moerloose P; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1993 May; 20(5):815-21. PubMed ID: 8336307
[TBL] [Abstract][Full Text] [Related]
7. CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis.
Vogt B; Führnrohr B; Müller R; Sheriff A
Autoimmunity; 2007 Jun; 40(4):295-8. PubMed ID: 17516213
[TBL] [Abstract][Full Text] [Related]
8. [The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Ketlinskiĭ SA; Alekseeva TG; Perumov ND; Simbirtsev AS
Ter Arkh; 1993; 65(12):51-4. PubMed ID: 8146772
[TBL] [Abstract][Full Text] [Related]
9. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
10. [Peculiarities of free radical and antioxidant statute in patients with systemic lupus erythematosus and rheumatoid arthritis].
Podoprigorova VG; Bobylev AA; Ivanova SM; Speranskiĭ AI
Biomed Khim; 2005; 51(5):536-41. PubMed ID: 16342671
[TBL] [Abstract][Full Text] [Related]
11. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.
Pool AJ; Whipp BJ; Skasick AJ; Alavi A; Bland JM; Axford JS
Rheumatology (Oxford); 2004 Jan; 43(1):43-8. PubMed ID: 12867581
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
Rosenau BJ; Schur PH
J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
15. [Stepwise extraction of the blood lipids of rheumatoid arthritis and systemic lupus erythematosus patients].
Bagirova GG
Lab Delo; 1987; (3):215-7. PubMed ID: 2438468
[No Abstract] [Full Text] [Related]
16. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.
Vakkalanka RK; Woo C; Kirou KA; Koshy M; Berger D; Crow MK
Arthritis Rheum; 1999 May; 42(5):871-81. PubMed ID: 10323442
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
[TBL] [Abstract][Full Text] [Related]
18. [The level of the tumor necrosis factor in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis].
Prokop'ev AA; Alekseeva TG; Zimina ZV; Ketlinskiĭ SA
Ter Arkh; 1993; 65(5):9-12. PubMed ID: 8036608
[TBL] [Abstract][Full Text] [Related]
19. [Morphological differentiation of peripheral blood lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus].
Brelińska-Peczalska R; Mackiewicz S
Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1287-90. PubMed ID: 1161565
[No Abstract] [Full Text] [Related]
20. The lupus erythematosus cell phenomenon: comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera.
Schett G; Rubin RL; Steiner G; Hiesberger H; Muller S; Smolen J
Arthritis Rheum; 2000 Feb; 43(2):420-8. PubMed ID: 10693884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
